Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Insulin secretion (mmu04911)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Abcc8
KLA  ATP  ATP+KLA
 NM_011510 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 (Abcc8), mRNA [NM_011510] KLA .98 1.00 1.03 .99 .96 .99 .98
ATP 1.00 .97 1.03 1.00 .98 .99 1.06
KLA/ATP 1.00 1.01 1.01 1.01 .94 .99 .99
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adcyap1
KLA  ATP  ATP+KLA
 NM_009625 adenylate cyclase activating polypeptide 1 (Adcyap1), mRNA [NM_009625] KLA 1.00 1.02 .98 .99 1.01 .99 .90
ATP 1.05 1.00 .93 .94 .98 .96 .96
KLA/ATP .99 .97 .99 .98 .92 .90 .94
Adcyap1r
1
KLA  ATP  ATP+KLA
 NM_007407 adenylate cyclase activating polypeptide 1 receptor 1 (Adcyap1r1), transcript variant 1, mRNA [NM_007407] KLA 1.03 1.02 .99 1.03 1.02 1.02 1.05
ATP 1.03 1.01 1.14 1.01 .99 1.02 1.01
KLA/ATP .97 .99 1.03 1.08 1.04 1.04 .98
AK043675
KLA  ATP  ATP+KLA
 AK043675 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830019B06 product:unclassifiable, full insert sequence. [AK043675] KLA 1.07 1.05 1.00 .98 1.05 1.02 1.00
ATP .92 1.07 .99 .93 1.01 1.01 1.02
KLA/ATP .96 .93 1.08 1.00 .94 .97 1.02
AK078587
KLA  ATP  ATP+KLA
 AK078587 11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] KLA 1.37 1.28 1.13 1.06 1.15 1.31 1.22
ATP 1.04 1.08 1.21 1.22 1.27 1.12 1.14
KLA/ATP 1.48 1.66 1.97 1.26 1.17 1.03 1.28
Atf2
KLA  ATP  ATP+KLA
 AK047405 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930056P03 product:activating transcription factor 2, full insert sequence. [AK047405] KLA 1.01 1.00 1.02 1.04 1.03 1.03 1.00
ATP .99 1.00 .95 1.01 1.04 .98 1.03
KLA/ATP 1.07 1.00 .98 .99 1.00 1.03 .93
Atf2
KLA  ATP  ATP+KLA
 NM_001025093 activating transcription factor 2 (Atf2), transcript variant 1, mRNA [NM_001025093] KLA 1.35 1.30 1.32 1.31 1.37 1.09 1.20
ATP 1.15 1.17 .99 1.11 1.22 1.39 1.28
KLA/ATP 1.38 1.42 1.21 1.28 1.17 1.33 1.69
Atf4
KLA  ATP  ATP+KLA
 NM_009716 activating transcription factor 4 (Atf4), mRNA [NM_009716] KLA .91 1.06 1.13 1.31 1.92 2.59 3.01
ATP 1.05 1.14 1.34 2.88 4.84 2.36 2.56
KLA/ATP 1.14 1.08 1.17 2.40 3.72 3.54 3.62
Atp1a1
KLA  ATP  ATP+KLA
 NM_144900 ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] KLA .78 .94 .68 .81 .62 .55 .75
ATP 1.02 1.05 .86 .85 1.77 2.54 1.11
KLA/ATP .83 .99 .80 .75 .91 1.15 .68
Atp1a2
KLA  ATP  ATP+KLA
 NM_178405 ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] KLA 1.03 .98 1.03 1.05 1.03 .98 1.02
ATP 1.03 .98 1.06 1.05 1.05 .93 1.07
KLA/ATP 1.04 1.05 1.02 1.02 .98 .92 1.02
Atp1a3
KLA  ATP  ATP+KLA
 AK053751 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] KLA .88 .87 .74 .80 .84 .88 .93
ATP .96 .83 .80 .88 .94 .89 1.15
KLA/ATP .89 .86 .79 .90 .93 .84 .92
Atp1a3
KLA  ATP  ATP+KLA
 NM_144921 ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] KLA .99 .87 .96 .86 .81 .61 .52
ATP 1.22 1.21 1.16 1.38 1.27 .92 1.30
KLA/ATP .96 1.10 1.17 1.42 1.11 .91 .93
Atp1b1
KLA  ATP  ATP+KLA
 NM_009721 ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] KLA .97 1.02 1.08 .98 .95 1.01 1.09
ATP 1.07 1.05 1.09 1.09 1.02 1.17 1.11
KLA/ATP .99 .99 .93 1.02 1.00 1.07 1.04
Atp1b2
KLA  ATP  ATP+KLA
 NM_013415 ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] KLA 1.18 1.09 1.11 1.12 1.16 1.12 1.15
ATP .95 .98 .99 1.26 1.06 1.10 1.07
KLA/ATP 1.15 1.16 1.09 1.19 1.27 1.13 1.02
Atp1b3
KLA  ATP  ATP+KLA
 NM_007502 ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] KLA 1.86 2.10 2.25 2.21 2.68 3.26 3.45
ATP 1.08 1.09 .93 1.13 1.55 2.14 2.38
KLA/ATP 1.95 2.10 1.84 2.34 2.20 2.96 4.69
Atp1b4
KLA  ATP  ATP+KLA
 NM_133690 ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] KLA .99 1.02 1.03 1.01 .95 .90 1.00
ATP 1.00 1.05 1.04 .98 1.07 .98 .97
KLA/ATP 1.00 1.05 1.03 1.04 .96 .97 1.01
Cacna1d
KLA  ATP  ATP+KLA
 NM_001083616 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] KLA 1.57 1.58 2.50 3.62 4.55 2.93 .99
ATP 1.12 .99 .97 .94 .75 1.71 1.48
KLA/ATP 1.47 1.51 1.82 1.56 1.67 2.93 4.60
Cacna1d
KLA  ATP  ATP+KLA
 NM_028981 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] KLA 1.20 1.26 1.43 1.62 2.07 1.66 1.00
ATP 1.03 1.03 .97 .97 .93 1.20 1.26
KLA/ATP 1.16 1.12 1.10 1.14 1.08 1.44 2.56
Cacna1f
KLA  ATP  ATP+KLA
 NM_019582 calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] KLA 1.03 .98 1.05 1.06 1.00 1.02 1.01
ATP 1.05 1.05 .95 .98 .97 .96 1.01
KLA/ATP 1.01 1.03 .94 1.01 1.01 1.00 .99
Cacna1s
KLA  ATP  ATP+KLA
 NM_001081023 calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] KLA 1.03 1.01 .96 1.06 1.00 1.00 1.05
ATP 1.01 .98 1.02 1.02 1.05 1.07 1.05
KLA/ATP .99 1.05 1.02 1.05 1.03 1.05 1.00
Camk2a
KLA  ATP  ATP+KLA
 NM_177407 calcium/calmodulin-dependent protein kinase II alpha (Camk2a), transcript variant 2, mRNA [NM_177407] KLA .98 .97 .98 .95 .97 1.02 .97
ATP .98 1.11 1.02 .89 .94 .89 .82
KLA/ATP .99 .95 1.02 .88 .88 .87 .87
Camk2b
KLA  ATP  ATP+KLA
 NM_007595 calcium/calmodulin-dependent protein kinase II, beta (Camk2b), mRNA [NM_007595] KLA 1.09 1.28 1.42 1.41 1.37 1.24 .68
ATP .94 .87 .95 .91 .67 .44 .48
KLA/ATP 1.16 1.24 1.40 1.13 1.14 .81 .49
Camk2d
KLA  ATP  ATP+KLA
 AK032524 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430579P05 product:calcium/calmodulin-dependent protein kinase II, delta, full insert sequence. [AK032524] KLA 1.31 1.45 1.42 1.21 1.34 1.18 1.16
ATP 1.04 1.29 1.39 1.24 .94 .91 1.22
KLA/ATP 1.46 1.64 1.42 1.24 1.00 .93 1.10
Camk2d
KLA  ATP  ATP+KLA
 NM_001025439 calcium/calmodulin-dependent protein kinase II, delta (Camk2d), transcript variant 1, mRNA [NM_001025439] KLA 1.76 1.75 1.72 1.89 1.47 1.55 1.24
ATP 1.06 1.06 .93 1.01 1.22 .98 2.28
KLA/ATP 1.84 1.78 1.40 1.57 1.07 .60 1.97
Camk2g
KLA  ATP  ATP+KLA
 NM_178597 calcium/calmodulin-dependent protein kinase II gamma (Camk2g), transcript variant 1, mRNA [NM_178597] KLA .23 .24 .23 .44 .70 .73 .70
ATP .91 .85 1.07 .86 .58 .59 .95
KLA/ATP .22 .20 .35 .25 .54 .59 .71
Cckar
KLA  ATP  ATP+KLA
 NM_009827 cholecystokinin A receptor (Cckar), mRNA [NM_009827] KLA 1.00 .97 1.05 1.07 .99 1.08 1.03
ATP 1.08 1.00 1.10 1.07 .94 1.00 .98
KLA/ATP .99 .98 .99 1.04 1.00 1.04 1.02
Chrm3
KLA  ATP  ATP+KLA
 AK051841 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230008K23 product:unclassifiable, full insert sequence. [AK051841] KLA .92 .97 1.02 1.05 .96 .99 1.00
ATP 1.00 .99 .99 .95 1.05 1.02 1.01
KLA/ATP .91 .98 1.06 1.07 .94 1.00 .94
Chrm3
KLA  ATP  ATP+KLA
 NM_033269 cholinergic receptor, muscarinic 3, cardiac (Chrm3), mRNA [NM_033269] KLA .91 .99 .98 .93 1.08 1.01 1.06
ATP .97 1.05 1.03 .95 .99 1.01 1.10
KLA/ATP 1.05 1.09 .99 1.00 .98 1.03 1.00
Creb1
KLA  ATP  ATP+KLA
 NM_009952 cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] KLA 1.42 1.33 1.16 .99 .83 .97 .92
ATP .92 .91 1.18 1.38 1.51 1.02 .75
KLA/ATP 1.34 1.31 1.49 1.37 1.71 1.05 .93
Creb3
KLA  ATP  ATP+KLA
 NM_013497 cAMP responsive element binding protein 3 (Creb3), mRNA [NM_013497] KLA 1.21 1.21 1.23 1.53 1.77 1.77 1.31
ATP 1.02 1.03 .99 1.05 .82 .83 1.48
KLA/ATP 1.15 1.18 1.20 1.26 1.13 1.15 1.86
Creb3l1
KLA  ATP  ATP+KLA
 NM_011957 cAMP responsive element binding protein 3-like 1 (Creb3l1), mRNA [NM_011957] KLA 1.18 1.17 1.53 1.28 1.22 1.11 1.23
ATP 1.01 1.09 .98 1.17 1.22 1.01 1.15
KLA/ATP 1.22 1.29 1.08 1.34 1.14 1.36 1.12
Creb3l2
KLA  ATP  ATP+KLA
 AK082964 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530025K05 product:unclassifiable, full insert sequence [AK082964] KLA .44 .38 .37 .40 .45 .42 .47
ATP .90 .78 1.22 .79 .54 .46 .44
KLA/ATP .41 .41 .49 .43 .50 .51 .23
Creb3l2
KLA  ATP  ATP+KLA
 NM_178661 cAMP responsive element binding protein 3-like 2 (Creb3l2), mRNA [NM_178661] KLA .98 .87 .76 .98 1.03 .87 1.12
ATP 1.20 1.18 1.50 1.35 .86 1.32 1.50
KLA/ATP .98 1.04 1.15 1.05 .79 1.27 1.25
Creb3l3
KLA  ATP  ATP+KLA
 NM_145365 cAMP responsive element binding protein 3-like 3 (Creb3l3), mRNA [NM_145365] KLA .66 .75 .65 .85 1.04 1.44 1.73
ATP 1.02 .98 .97 1.09 .85 .69 1.11
KLA/ATP .70 .66 .71 .83 .80 .85 1.05
Creb3l4
KLA  ATP  ATP+KLA
 NM_030080 cAMP responsive element binding protein 3-like 4 (Creb3l4), mRNA [NM_030080] KLA 1.55 1.42 1.51 1.73 1.76 2.54 1.38
ATP 1.07 .81 .89 1.08 .94 1.08 1.08
KLA/ATP 1.44 1.38 1.44 1.25 1.30 1.26 2.24
Creb5
KLA  ATP  ATP+KLA
 AK051306 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130032G03 product:unclassifiable, full insert sequence. [AK051306] KLA 2.18 2.13 2.42 1.97 1.57 1.94 1.98
ATP 1.11 1.09 1.47 1.74 1.36 1.44 1.62
KLA/ATP 2.55 2.77 3.02 3.15 2.51 2.52 2.61
Creb5
KLA  ATP  ATP+KLA
 NM_172728 cAMP responsive element binding protein 5 (Creb5), mRNA [NM_172728] KLA 3.70 3.60 2.84 2.39 1.92 2.81 1.84
ATP .92 .89 1.19 1.93 1.51 1.55 1.44
KLA/ATP 3.16 3.51 4.33 5.35 5.78 3.23 3.03
Crebl1
KLA  ATP  ATP+KLA
 NM_017406 cAMP responsive element binding protein-like 1 (Crebl1), mRNA [NM_017406] KLA 1.22 1.30 1.32 1.34 1.51 1.52 1.75
ATP 1.13 1.32 1.16 1.66 1.06 .93 1.54
KLA/ATP 1.37 1.25 1.21 1.74 1.04 1.01 2.07
Ffar1
KLA  ATP  ATP+KLA
 NM_194057 free fatty acid receptor 1 (Ffar1), mRNA [NM_194057] KLA .94 1.02 1.05 1.00 .98 1.07 1.09
ATP .96 1.04 .98 1.02 .94 .95 1.05
KLA/ATP 1.12 1.04 .93 1.02 1.05 1.04 1.07
Fxyd2
KLA  ATP  ATP+KLA
 NM_052823 FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] KLA 1.07 .97 1.09 .98 1.02 .96 .83
ATP 1.07 1.22 1.00 1.14 1.00 1.22 4.11
KLA/ATP 1.06 1.11 .96 1.13 .98 1.01 1.02
Gcg
KLA  ATP  ATP+KLA
 AK050538 adult pancreas islet cells cDNA, RIKEN full-length enriched library, clone:C820012C23 product:unclassifiable, full insert sequence [AK050538] KLA 1.02 1.03 1.02 1.04 1.01 .95 .98
ATP .95 .95 1.02 .98 .93 1.06 1.02
KLA/ATP 1.02 1.02 1.07 1.24 1.07 1.05 1.02
Gcg
KLA  ATP  ATP+KLA
 NM_008100 glucagon (Gcg), mRNA [NM_008100] KLA 1.15 1.16 1.18 1.14 1.12 1.11 1.07
ATP 1.00 1.01 1.05 1.06 1.34 1.43 1.08
KLA/ATP 1.15 1.16 1.27 7.81 6.64 5.01 1.81
Gck
KLA  ATP  ATP+KLA
 NM_010292 glucokinase (Gck), mRNA [NM_010292] KLA 1.03 .99 1.04 1.02 .97 .98 1.00
ATP 1.01 .97 1.08 .99 1.06 .98 .96
KLA/ATP 1.06 1.01 .96 .98 .98 1.01 1.01
Gip
KLA  ATP  ATP+KLA
 NM_008119 gastric inhibitory polypeptide (Gip), mRNA [NM_008119] KLA 1.07 1.03 .94 1.06 1.10 1.03 1.05
ATP 1.05 1.00 .96 1.00 .96 .97 .97
KLA/ATP .92 .95 1.04 1.00 .95 1.03 1.02
Glp1r
KLA  ATP  ATP+KLA
 NM_021332 glucagon-like peptide 1 receptor (Glp1r), mRNA [NM_021332] KLA .99 .97 .98 .95 1.03 .99 .99
ATP .99 .99 .97 1.01 .97 .99 1.02
KLA/ATP .97 1.03 1.02 1.00 .98 .98 1.01
Gna11
KLA  ATP  ATP+KLA
 NM_010301 guanine nucleotide binding protein, alpha 11 (Gna11), mRNA [NM_010301] KLA .62 .65 .69 .79 .94 1.00 .96
ATP 1.00 .94 .63 .53 .79 1.13 1.22
KLA/ATP .64 .60 .56 .55 .81 1.16 1.18
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Gpr119
KLA  ATP  ATP+KLA
 NM_181751 G-protein coupled receptor 119 (Gpr119), mRNA [NM_181751] KLA 1.14 1.27 1.04 1.08 1.10 1.04 .97
ATP .98 1.10 1.06 .97 1.03 1.00 1.04
KLA/ATP 1.10 1.15 1.39 1.08 .99 .94 1.04
Ins1
KLA  ATP  ATP+KLA
 NM_008386 insulin I (Ins1), mRNA [NM_008386] KLA 1.00 .99 .99 1.03 1.01 .98 1.06
ATP .97 1.03 1.00 1.03 .99 1.07 1.05
KLA/ATP 1.03 .93 .98 1.04 1.07 1.03 1.01
Ins2
KLA  ATP  ATP+KLA
 NM_008387 insulin II (Ins2), mRNA [NM_008387] KLA .99 1.00 1.00 1.01 1.00 1.02 1.00
ATP 1.01 .99 1.00 1.00 .98 .99 1.01
KLA/ATP .99 1.01 1.00 .98 .99 .99 .98
Itpr3
KLA  ATP  ATP+KLA
 NM_080553 inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] KLA .55 .51 .45 .41 .34 .34 .45
ATP 1.01 .92 1.02 .57 .46 .34 1.22
KLA/ATP .56 .48 .48 .29 .33 .27 .65
Kcnj11
KLA  ATP  ATP+KLA
 NM_010602 potassium inwardly rectifying channel, subfamily J, member 11 (Kcnj11), mRNA [NM_010602] KLA 1.00 1.02 1.03 .96 1.03 1.05 .92
ATP 1.01 1.03 1.06 1.02 1.01 1.00 1.09
KLA/ATP 1.00 1.01 1.06 .98 .99 1.02 .98
Kcnma1
KLA  ATP  ATP+KLA
 NM_010610 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (Kcnma1), mRNA [NM_010610] KLA 1.04 1.08 .96 .98 1.01 1.08 .96
ATP 1.03 .96 .99 .97 .98 .95 .99
KLA/ATP .99 1.07 1.04 1.04 .99 .95 .93
Kcnmb1
KLA  ATP  ATP+KLA
 AK039715 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330094H22 product:unclassifiable, full insert sequence [AK039715] KLA 1.09 .99 .98 1.03 1.02 1.06 1.02
ATP 1.03 1.04 1.03 1.01 .96 1.00 1.05
KLA/ATP 1.03 .98 .91 1.04 .98 1.04 1.03
Kcnmb1
KLA  ATP  ATP+KLA
 NM_031169 potassium large conductance calcium-activated channel, subfamily M, beta member 1 (Kcnmb1), mRNA [NM_031169] KLA .99 .97 .95 .99 .99 1.02 .95
ATP .95 1.04 .91 .95 .97 1.01 .98
KLA/ATP 1.11 .99 1.07 .94 .94 .90 .99
Kcnmb2
KLA  ATP  ATP+KLA
 NM_028231 potassium large conductance calcium-activated channel, subfamily M, beta member 2 (Kcnmb2), mRNA [NM_028231] KLA .99 1.06 1.04 1.09 .96 1.09 1.03
ATP .98 1.12 1.02 1.00 .98 1.07 1.06
KLA/ATP 1.06 .97 1.02 1.03 1.01 .98 1.06
Kcnmb4
KLA  ATP  ATP+KLA
 NM_021452 potassium large conductance calcium-activated channel, subfamily M, beta member 4 (Kcnmb4), mRNA [NM_021452] KLA 1.04 1.01 1.00 .95 1.04 1.01 .99
ATP .98 .94 1.12 1.03 1.00 1.00 1.01
KLA/ATP .99 1.06 .98 1.00 1.09 1.14 .98
Kcnn1
KLA  ATP  ATP+KLA
 NM_032397 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 (Kcnn1), mRNA [NM_032397] KLA .88 1.00 1.27 .97 .91 1.00 1.12
ATP .96 1.01 1.04 1.05 .98 .90 1.11
KLA/ATP .88 .94 .96 1.01 1.02 .84 .85
Kcnn2
KLA  ATP  ATP+KLA
 NM_080465 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 (Kcnn2), mRNA [NM_080465] KLA 1.00 1.02 1.00 1.03 1.02 1.01 1.01
ATP 1.00 1.00 1.02 1.01 1.01 1.01 1.02
KLA/ATP .99 1.02 1.01 1.01 1.02 .99 1.00
Kcnn3
KLA  ATP  ATP+KLA
 NM_080466 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 (Kcnn3), mRNA [NM_080466] KLA 1.05 1.10 1.02 1.00 1.02 1.01 .98
ATP .96 1.09 1.01 .99 1.01 .95 1.03
KLA/ATP .91 .99 1.02 .95 1.00 1.03 1.03
Kcnn4
KLA  ATP  ATP+KLA
 NM_008433 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 (Kcnn4), mRNA [NM_008433] KLA .89 .85 .74 .69 .78 1.04 .98
ATP .95 1.03 .82 .84 .81 .44 .70
KLA/ATP 1.04 .94 .65 .74 .56 .43 .57
Kcnu1
KLA  ATP  ATP+KLA
 NM_008432 potassium channel, subfamily U, member 1 (Kcnu1), mRNA [NM_008432] KLA .98 1.10 1.09 1.12 1.07 .98 1.07
ATP 1.09 1.10 1.10 1.05 .98 1.03 1.08
KLA/ATP 1.02 1.01 1.14 1.04 1.07 1.10 1.10
Mm.13153
0
KLA  ATP  ATP+KLA
 161086915 Unknown KLA 1.00 1.07 1.14 1.08 .97 1.00 .93
ATP 1.04 .99 1.00 .95 .99 1.02 .90
KLA/ATP 1.08 1.18 1.14 1.16 1.04 1.06 1.08
Mm.14627
5
KLA  ATP  ATP+KLA
 160707977 Unknown KLA .85 .98 .96 .93 .91 .92 .90
ATP 1.04 1.03 .99 1.28 1.06 1.01 .84
KLA/ATP .96 .94 1.07 1.64 1.21 1.05 .84
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Pclo
KLA  ATP  ATP+KLA
 NM_001110796 piccolo (presynaptic cytomatrix protein) (Pclo), transcript variant 2, mRNA [NM_001110796] KLA .99 1.02 1.01 1.02 .97 .99 1.01
ATP 1.04 1.00 1.01 .97 .98 .99 .98
KLA/ATP .94 .99 .99 .94 .98 1.00 .92
Pdx1
KLA  ATP  ATP+KLA
 NM_008814 pancreatic and duodenal homeobox 1 (Pdx1), mRNA [NM_008814] KLA .92 1.07 1.11 1.03 1.02 1.09 1.06
ATP 1.08 1.02 1.02 1.03 1.09 1.07 1.01
KLA/ATP 1.03 1.12 .86 1.08 1.27 1.11 1.13
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Rab3a
KLA  ATP  ATP+KLA
 NM_009001 RAB3A, member RAS oncogene family (Rab3a), mRNA [NM_009001] KLA .28 .28 .44 .66 .92 .88 .84
ATP 1.15 1.23 1.30 .97 .30 .42 .87
KLA/ATP .29 .31 .40 .34 .57 .62 .63
Rapgef4
KLA  ATP  ATP+KLA
 AK080066 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530056J20 product:unclassifiable, full insert sequence. [AK080066] KLA .99 1.06 .98 1.00 .95 1.02 1.01
ATP .98 1.05 1.02 1.09 .99 1.03 1.01
KLA/ATP .98 .98 .91 1.08 .96 .96 .96
Rapgef4
KLA  ATP  ATP+KLA
 NM_019688 Rap guanine nucleotide exchange factor (GEF) 4 (Rapgef4), mRNA [NM_019688] KLA 1.00 .98 1.00 1.01 1.01 1.02 1.02
ATP .98 .99 .99 1.01 1.00 1.03 1.01
KLA/ATP 1.04 1.07 1.02 1.03 1.01 1.03 .97
Rims2
KLA  ATP  ATP+KLA
 AK032619 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430709C16 product:Rab3 interacting protein 1, full insert sequence. [AK032619] KLA .89 .93 1.02 .94 .93 .98 1.01
ATP 1.05 1.03 .96 .88 .91 .96 .95
KLA/ATP .95 1.00 .93 .90 .89 .98 1.05
Rims2
KLA  ATP  ATP+KLA
 NM_053271 regulating synaptic membrane exocytosis 2 (Rims2), mRNA [NM_053271] KLA .93 .98 .93 1.01 .92 1.13 1.25
ATP 1.01 .97 1.05 1.03 .91 1.02 .98
KLA/ATP .99 .98 .89 1.01 .93 1.17 1.36
Ryr2
KLA  ATP  ATP+KLA
 BC043140 ryanodine receptor 2, cardiac, mRNA (cDNA clone IMAGE:6822493), complete cds. [BC043140] KLA .97 1.03 1.01 1.03 1.03 1.01 1.05
ATP .99 .98 1.03 1.02 1.01 1.09 1.04
KLA/ATP .98 1.00 .98 1.04 1.04 1.06 1.00
Ryr2
KLA  ATP  ATP+KLA
 NM_023868 ryanodine receptor 2, cardiac (Ryr2), mRNA [NM_023868] KLA 1.04 1.02 1.00 1.00 1.03 .97 .96
ATP .95 1.04 1.00 .94 .98 1.01 1.08
KLA/ATP .99 .97 1.02 1.03 1.00 .98 1.00
Slc2a1
KLA  ATP  ATP+KLA
 NM_011400 solute carrier family 2 (facilitated glucose transporter), member 1 (Slc2a1), mRNA [NM_011400] KLA 1.31 1.46 1.10 1.68 1.75 1.95 2.34
ATP .88 .90 1.32 1.99 3.40 10.49 1.93
KLA/ATP 1.13 1.25 1.71 2.14 3.71 6.31 4.63
Slc2a2
KLA  ATP  ATP+KLA
 NM_031197 solute carrier family 2 (facilitated glucose transporter), member 2 (Slc2a2), mRNA [NM_031197] KLA 1.01 1.03 .97 1.00 1.01 1.02 1.04
ATP 1.02 .97 1.07 1.00 1.00 1.03 1.00
KLA/ATP 1.01 1.01 .95 1.00 1.05 1.02 1.01
Snap23
KLA  ATP  ATP+KLA
 NM_009222 synaptosomal-associated protein 23 (Snap23), mRNA [NM_009222] KLA 1.27 1.33 1.46 1.36 1.33 1.07 .93
ATP .94 1.02 1.17 1.18 1.02 1.03 1.11
KLA/ATP 1.14 1.32 1.43 1.37 1.13 1.05 1.20
Snap25
KLA  ATP  ATP+KLA
 M22012 synaptosomal associated protein-25 (Snap25) mRNA, complete cds. [M22012] KLA 1.04 1.01 1.00 1.06 1.05 1.07 .99
ATP .98 1.00 .98 .93 .97 1.04 1.01
KLA/ATP .97 1.00 1.09 1.03 .95 .99 1.03
Snap25
KLA  ATP  ATP+KLA
 NM_011428 synaptosomal-associated protein 25 (Snap25), mRNA [NM_011428] KLA .99 1.00 .96 1.03 1.05 1.02 1.01
ATP .98 .99 1.01 1.06 1.02 1.09 .99
KLA/ATP .98 1.02 1.01 1.00 1.03 .98 1.07
Stx1a
KLA  ATP  ATP+KLA
 NM_016801 syntaxin 1A (brain) (Stx1a), mRNA [NM_016801] KLA .84 .77 .70 .80 .75 .71 .82
ATP 1.00 1.20 .92 .94 1.65 1.16 1.04
KLA/ATP .87 .76 .71 .82 1.14 .91 .88
Trpm4
KLA  ATP  ATP+KLA
 NM_175130 transient receptor potential cation channel, subfamily M, member 4 (Trpm4), mRNA [NM_175130] KLA 1.46 1.64 1.54 1.45 1.64 1.31 .93
ATP 1.04 1.06 1.00 1.00 1.84 1.29 .91
KLA/ATP 1.56 1.56 1.42 1.70 3.00 1.69 1.10
Vamp2
KLA  ATP  ATP+KLA
 NM_009497 vesicle-associated membrane protein 2 (Vamp2), mRNA [NM_009497] KLA .99 1.02 1.03 1.07 1.34 1.25 1.58
ATP 1.03 1.12 .88 1.22 .94 .99 1.62
KLA/ATP 1.03 1.15 .82 1.10 .87 .93 1.86